BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 728167)

  • 1. The effect of glucagon on the heart muscle: relation between metabolic processes and contractility.
    Krutý F; Gvozdják A; Bada V; Niederland TR; Gvozdják J; Kaplán M
    Biochem Pharmacol; 1978; 27(17):2153-5. PubMed ID: 728167
    [No Abstract]   [Full Text] [Related]  

  • 2. A protective effect of a mild acidosis on hypoxic heart muscle.
    Nayler WG; Ferrari R; Poole-Wilson PA; Yepez CE
    J Mol Cell Cardiol; 1979 Oct; 11(10):1053-71. PubMed ID: 42803
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the mitochondrial respiratory chain in isolated atria--a comparison of rotenone and amytal.
    Liu M; Siess M; Hoffmann PC
    Biochem Pharmacol; 1970 Jan; 19(1):197-207. PubMed ID: 4323654
    [No Abstract]   [Full Text] [Related]  

  • 4. The cardiodynamic and metabolic effects of glucagon.
    Simaan J; Fawaz G
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):277-83. PubMed ID: 1004638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of creatine on the developed tension and metabolic kinetics of isolated rabbit atria after prolonged cold storage.
    Kondo N; Shibata S
    Gen Pharmacol; 1983; 14(6):597-602. PubMed ID: 6229447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanochemistry of cardia muscle. 3. Effects of norepinephrine on the utilization of high-energy phosphates.
    Chandler BM; Sonnenblick EH; Pool PE
    Circ Res; 1968 Jun; 22(6):729-35. PubMed ID: 5659813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Control of myocardial contractility via action on intracellular energy transport].
    Chazov EI; Rozenshtraukh LV; Saks VA; Smirnov VN; Undrovinas AI
    Patol Fiziol Eksp Ter; 1976; (4):7-13. PubMed ID: 1086996
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of glucagon on calcium exchangeability, coronary blood flow, myocardial function and high energy phosphate stores.
    Nayler WG; McInnes I; Chipperfield D; Carson V; Daile P
    J Pharmacol Exp Ther; 1970 Feb; 171(2):265-75. PubMed ID: 5459062
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic effects of inosine and uridine in rabbit hearts and rat skeletal muscles.
    Kypson J; Hait G
    Biochem Pharmacol; 1977 Sep; 26(17):1585-91. PubMed ID: 901578
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of energy transport in heart cells. Intracellular creatine content as a regulatory factor of frog heart energetics and force of contraction.
    Saks VA; Rosenshtraukh LV; Undrovinas AI; Smirnov VN; Chazov EI
    Biochem Med; 1976 Aug; 16(1):21-36. PubMed ID: 1087559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic processes in the myocardium during the early stages of postnatal ontogenesis and the effect of cardiac glycosides (review of the literature)].
    Chekman IS; Viktorov AP
    Farmakol Toksikol; 1978; 41(6):723-30. PubMed ID: 363451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of vitamin E on cardiac muscle function and metabolism during anoxia and after reoxygenation (author's transl)].
    Guarnieri C; Davalli P; Ferrari R; Caldarera CM
    G Ital Cardiol; 1979; 9(8):828-35. PubMed ID: 549797
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation.
    Kelm M; Schäfer S; Dahmann R; Dolu B; Perings S; Decking UK; Schrader J; Strauer BE
    Cardiovasc Res; 1997 Nov; 36(2):185-94. PubMed ID: 9463630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and some properties of isolated beating myocytes from adult rabbit heart.
    Dani AM; Cittadini A; Flamini G; Festuccia G; Terranova T
    J Mol Cell Cardiol; 1977 Sep; 9(9):777-84. PubMed ID: 903982
    [No Abstract]   [Full Text] [Related]  

  • 15. Uncoupling of work and adenosine triphosphate utilization in Daunorubicin cardiotoxicity.
    Dow JW; Burns JH
    Biochem Soc Trans; 1978; 6(5):928-9. PubMed ID: 744348
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of inhibition of oxidative phosphorylation and glycolysis on contractility and high-energy phosphate content in cultured chick heart cells.
    Doorey AJ; Barry WH
    Circ Res; 1983 Aug; 53(2):192-201. PubMed ID: 6883645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Energy metabolism of right ventricular myocardium following section of the left coronary artery].
    Razumnaia NM
    Kardiologiia; 1973 Mar; 13(3):62-6. PubMed ID: 4717187
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial metabolism for the toxicologist.
    Merin RG
    Environ Health Perspect; 1978 Oct; 26():169-74. PubMed ID: 720313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of regional myocardial lidocaine infusion on high energy phosphates.
    Schaefer S; Schwartz GG; Steinman S; Garcia J; Trocha SD; Weiner MW; Massie BM
    J Mol Cell Cardiol; 1994 Dec; 26(12):1601-11. PubMed ID: 7731055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.